secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monopar Therapeutics (MNPR)
CIK:        0001645469
Form:       8-K
Filed at:   2024-12-23T23:59:59+00:00
Accession:  0001437749-24-038286
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Monopar raises ~$37.6M via registered offering and private placement of pre-funded warrants
--------------------------------------------------------------------------------

- Registered offering of 798,655 shares at $23.79 per share; concurrent private placement of pre-funded warrants for 882,761 shares at $23.789 each.
- Pre-funded warrants have exercise price of $0.001 per share; total combined net proceeds ~$37.6M after discounts and expenses.
- Closings expected December 23, 2024; underwriting agreement with Piper Sandler & Co. as representative.
- Securities Purchase Agreement with an institutional investor; Registration Rights Agreement requires resale registration within 30 days of closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645469/000143774924038286/0001437749-24-038286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645469/000143774924038286/mnpr20241220_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-038286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer